Factors Affecting the Use of Hospice Care and Timing of Its Initiation: Comparing Single and Combined Hospice Users Among Korean Adult Cancer Decedents Authors: Ohk Kyeong Min, Kyunghee Chae, Hyunjong Song Published: 2026 ABSTRACT PurposeThis study aimed to identify the factors affecting the use of single and combined hospice care and timing of hospice initiation, thereby providing a basis for improving the continuity and quality of hospice care.MethodsStatistics on cancer-related deaths in 2019 from Statistics Korea and administrative data from the National Health Insurance Service were obtained. Multiple logistic regression and multiple linear regression analyses were performed to identify factors associated with combined (versus single) hospice use and the timing of hospice initiation before death, based on Andersen’s model, among 19,334 patients who used hospice care.ResultsAmong the participants, 18.7% used combined hospice care. Factors associated with the utilization of combined hospice care were gender, income, residential area, location of the primary medical institution, type of the primary medical institution, whether the primary medical institution and residential area were in the same location, Charlson Comorbidity Index (CCI), and primary cancer type. Combined hospice users initiated hospice care 25.7 days earlier than single hospice users. Patients who initiated hospice care early were in their 60s, resided in a capital city, used medical institutions located in urban areas and designated as hospice-specialized institutions, had CCI ≥2, and were diagnosed with prostate cancer.ConclusionTo improve accessibility to combined hospice care for patients with terminal cancer in Korea, care should be provided equitably based on patients’ disease status and region of residence. INTRODUCTION In 2023, 87,112 of the 352,511 deaths reported in Korea—that is, 24.71%—were caused by cancer [1]. This corresponds to a cancer mortality rate of 170.3 per 100,000 people, representing a 2.6% increase from the previous year [1]. The cancer mortality rate is increasing annually, and cancer is now the leading cause of death in Korea. To provide hospice and palliative care, which aims to provide comprehensive evaluation and treatment of physical, psychosocial, and spiritual needs, including pain and symptom relief, to patients with terminal cancer or those in the terminal stage of life, and their families, Korea enacted the Act on Decisions on Life-sustaining Treatment for Patients in Hospice and Palliative Care or at the End of Life in 2016 and 2017, respectively. In Korea, National Health Insurance covers inpatient hospice care provided by independent hospice units, consultative hospice, and home-based hospice care provided in the home or community settings [2]. The Korean Ministry of Health and Welfare recommends the integrated provision of three types of hospice services based on the needs of terminally ill patients and their families, and according to the course of the disease [3]. Through this system, terminally ill patients can choose to remain at home or in a general ward or outpatient clinic without a change in the medical staff in charge; early initiation of hospice and palliative care is encouraged for patients, and continuity of treatment is ensured for inpatients upon discharge [4]. The benefits of combining different types of hospice care are supported by prior research. According to Yun et al. [5], patients with cancer who used a combination of hospital and home-based hospice care had the lowest probability and frequency of receiving intensive care, whereas patients using only home-based hospice care had the highest probability and frequency of receiving supportive care. Tang et al. [6] reported that patients who received both home and inpatient hospice services were referred sooner, which extended their duration of care. Park et al. [7] empirically demonstrated that consultative hospice serves as a “bridge” to inpatient hospice, showing that patients who used both types of hospice care received care for a significantly longer average period than those who used only consultative hospice. These studies suggest that an integrated system combining home, inpatient, and consultative hospice services promotes more timely and appropriate care, ultimately enhancing the quality of end-of-life care. According to Kim et al. [8], because hospice care was first introduced as an inpatient service in Korea. Inpatient hospice care, which has the most providers, was used the most. However, recent trends indicate a decrease in the use of inpatient hospice services and an increase in the use of home and consultative services [8]. Although studies have explored the use of inpatient hospice care [9,10], consultative hospice care [11], and home-based hospice care [12], research on the use of combined hospice services remains scarce. The factors influencing hospice care utilization are multidimensional, spanning individual, structural, and clinical dimensions. To systematically examine these factors, this study drew on Andersen’s behavioral model of health services use—a widely applied framework for explaining healthcare utilization [13]. The model posits that health service use is determined by three groups of factors: predisposing factors (demographic and social characteristics that exist prior to illness), enabling factors (resources and conditions that facilitate or impede access, such as income, region, and characteristics of the medical institution), and need factors (the individual’s clinical status and severity of illness). The model is well suited to the present study because combined hospice use in Korea depends not only on patient characteristics but also on the regional and institutional availability of hospice resources. Framing the analysis within this model enables the determinants of combined hospice use and the timing of its initiation to be examined in a structured, theoretically grounded manner. Accordingly, this study aimed to identify the factors affecting the use of single and combined hospice care and the timing of hospice initiation, thereby providing a basis for improving the continuity and quality of hospice care. METHODS 1. Research design This study employed a retrospective, cross-sectional design using secondary data analysis. Nationwide administrative and mortality data from South Korea for 2019 were analyzed to identify factors associated with the type of hospice care used and the timing of its initiation. 2. Data sources and participants This study used two main sources of data: the Korean National Health Insurance Service (NHIS) and Statistics Korea. The NHIS database captures Koreans’ healthcare use based on medical claim data from medical institutions, whereas the Statistics Korea database provides information on the cause and date of death of deceased patients. This study was reviewed and approved by the Institutional Review Board of the university with which the researcher was affiliated (IRB No. 1040782-210618-HR-11-84). The participants were patients with a confirmed cancer diagnosis who were registered as beneficiaries of the “Special Co-payment Reduction Program for Severe Diseases.” This program significantly reduces the co-payment rate for patients with designated critical illnesses, such as cancer. From January 1 to December 31, 2019, the Statistics Korea database reported 91,553 cancer-related deaths, and participants were identified by merging the health insurance claims data from the NHIS with data on these deaths. Of the total 91,558 participants, after excluding 2,359 individuals under the age of 18 and those who had not used medical services in the six months prior to death, 19,334 patients who had claims for hospice services were included in the final analysis. 3. Study variables The dependent variables were single and combined hospice care use, and the timing of hospice initiation. Single hospice use refers to the use of only inpatient, consultative, or home hospice cares, whereas combined hospice use refers to the use of two or more types of hospice care. The initiation time was defines as the day hospice care commenced. The independent variables were selected based on a review of previous studies using Andersen’s healthcare utilization model [13]. Accordingly, predisposing factors included sex and age; enabling factors included income level, residential area, location of the primary medical institution, type of the primary medical institution, whether the primary medical institution was designated as a hospice, and whether the primary medical institution was located in the same area as the residential area; and need factors included cancer type and comorbidity. Income levels were divided among health insurance enrollees into five categories based on the difference in cancer hospitalization healthcare use by income class, with medical aid recipients classified as ‘0’ [14]. Primary medical institutions were defined as those at which patients were hospitalized more than twice for the same primary cancer over a period of six months [15]. Regional classification varied across previous studies [5,16]. This study considered data on the number of cancer-related deaths by province, number of hospice beds, and distribution of hospice institutions [17], and divided regions into capital city, metropolitan cities, capital area, and the rest of the country. Since it was anticipated that the primary medical institution would affect hospice use if it was a hospice-specialized institution, patients with terminal cancer were classified as residing in the same region if the primary medical institution they used during the six months before death was located in the same metropolitan government. The type of cancer was classified as the type of cancer at the time of diagnosis and registration. Since the types of cancer were diverse, this study classified cancer into 12 types based on the results of previous studies [5,18], the top seven causes of cancer-related deaths in men and women in 2019 according to Statistics Korea, and the data analyzed in this study. The Charlson Comorbidity Index (CCI), which is commonly applied in studies using Korean health insurance administrative data [19], was used to assess comorbidity. 4. Data analyses Percentages, means, and standard deviations were utilized to describe the general characteristics and the timing of hospice initiation according to the type of hospice used. Chi-square tests were performed to compare the distribution of general characteristics between single and combined hospice users. Differences in the timing of hospice initiation according to the type of hospice used and other characteristics were examined using independent t-tests. Multiple logistic regression and multiple linear regression analyses were then performed to determine the factors associated with the type of hospice care used and the timing of its initiation before death. For the multiple logistic regression, the type of hospice care was coded as a binary variable: combined hospice use was coded as 1 and single hospice use as 0 (reference), with an odds ratio (OR) greater than 1 indicating a higher likelihood of combined hospice use than single hospice use. For the multiple linear regression, the timing of hospice initiation was operationalized as a continuous variable defined as the number of days from the first day of hospice care to death, with a positive coefficient indicating earlier initiation. For these analyses, the enter method was adopted, and the absence of multicollinearity was confirmed, with all variance inflation factor (VIF) values being below 10. Analyses were performed using SAS version 9.4 for Windows (SAS Institute Inc., Seoul, South Korea). All tests were two-tailed, and statistical significance was set at a P-value of 0.05. RESULTS 1. Participants’ characteristics and initiation time Among the 19,334 participants, 18.7% (3,611) used combination-type hospice. The most prevalent combination was inpatient and consultative services (n=2,074, 57.4%), followed by inpatient and home-based services (n=1,079, 29.9%). A smaller proportion of patients used all three service types (n=333, 9.2%), while the combination of consultative and home-based services was the least frequent (n=125, 3.5%). The proportion of women; those aged ≤69 years; those in the 81~100th percentile of income; those living in cities, such as a capital city, metropolitan city, and the capital area; those whose primary medical institutions were in capital and metropolitan cities; those whose primary medical institutions were designated as hospice institutions; those with a CCI ≥2; and those with colon, bile duct, and pancreatic cancers were higher among combination-type than single-type hospice users. Among single-type hospice users, the proportion of patients with lung cancer was higher than that of combination-type hospice users (Table 1). The 19,334 participants began using hospice care 34.1 days (34.1±37.2) before death, with mean durations of 29.2 (29.2±33.8) and 55.3 (55.3±43.1) days for single- and combination-type users, respectively. Women, patients aged ≥80 years, those in the 0% income bracket, residents of a capital city, patients whose primary medical institutions were located in metropolitan cities, those whose primary medical institutions were clinics, whose primary medical institution was located in the same area as their residence, whose primary medical institutions were designated as hospices, those with CCI ≥2, and those with prostate cancer initiated hospice care relatively sooner than others. This trend was similar for both single- and combination-type hospice users. However, among single-type hospice users, patients whose primary medical institutions were located in a metropolitan city started using hospice care earlier, whereas among combination-type hospice users, those whose primary medical institutions were located in other areas started using hospice care earlier (Table 1). 2. Factors affecting combination-type hospice use When organized according to Andersen’s model, enabling factors—residential area, location and type of the primary medical institution, congruence between residence and institution location, and hospice designation—showed the strongest and most consistent associations with combined hospice use. The predisposing factor of gender and the need factors of comorbidity and cancer type were associated with combination-type hospice use to a lesser extent. The key factors influencing the use of combination-type hospice were gender, income, residential area, location of the primary medical institution, type of the primary medical institution, whether the location of the primary medical institution was the same as that of the patient’s residence, designation of the primary medical institution as a hospice, CCI, and primary cancer type. The OR for men was 0.867 (95% CI: 0.800~0.938), and that for the highest income level (81~100%) was 1.160 (95% CI: 1.031~1.306). By residential area, the probability of using combined hospice was higher in metropolitan cities (OR=1.312, 95% CI: 1.153~1.492) and the capital area (OR=1.380, 95% CI: 1.186~1.606) than in other areas. Regarding the location of the patients’ primary medical institutions, the ORs for a capital city and metropolitan cities were 1.595 (95% CI=1.333~1.907) and 1.752 (95% CI: 1.516~2.025), respectively, indicating a higher probability of using combination-type hospice than in other regions. Patients who used general hospitals (OR=1.303, 95% CI: 1.194~1.423) and clinics (OR=1.276, 95% CI: 1.052~1.547) had a higher probability of using combination-type hospice, while those who used hospitals had a lower probability (OR=0.517, 95% CI: 0.429~0.623) than patients who used tertiary hospitals. When the primary medical institution was a designated hospice, the probability of using a combined hospice was higher (OR=2.716, 95% CI: 2.419~3.05) than when not designated as a hospice. In cases where a medical institution in another region was used, rather than in cases where the residential area and primary medical institution were the same, the probability of using a combined hospice was lower (OR=0.869, 95% CI: 0.784~0.963). According to comorbidity, ≥2 points significantly increased the probability of using a combined hospice at 1.23 (95% CI: 1.084~1.396). By cancer types, the ORs for pancreatic, colon, lung, and leukemia were 1.377 (95% CI: 1.2~1.581), 1.334 (95% CI: 1.17~1.52), 0.982 (95% CI: 0.866~1.115), and 0.673 (95% CI: 0.41~1.105), respectively (Table 2). 3. Factors affecting the initiation of hospice care before death In the case of combined hospice use, hospice service initiation occurred 25.7 days earlier than in the case of single hospice use, which was statistically significant. According to age, those in their 60s started 2.8 days earlier than those in the reference group aged ≥80 years, and those in their 70s started 2.6 days earlier, which was statistically significant. For patients who resided in a capital city, hospice care was initiated 3.8 days earlier than in the reference group of other regions, whereas hospice care was initiated 2.3 days later in metropolitan cities, which was significant. Patients who used medical institutions primarily in a capital city, metropolitan cities, and capital areas initiated hospice care earlier. Patients whose primary medical institutions were general hospitals, clinics, and nursing hospitals all had earlier and statistically significantly different initiation of hospice services than those whose primary medical institutions were upper-level general hospitals. In the case of medical institutions designated as hospice-specialized institutions, hospice services were used 9.2 days earlier than in those not designated as such. According to comorbidity, patients with high severity scores of ≥2 initiated hospice care 7.4 days earlier than those with scores of 0, and this difference was statistically significant. Regarding cancer types, patients with prostate cancer initiated hospice care 6.4 days earlier than those with other cancer types, whereas those with leukemia initiated hospice care 8.3 days later than those with other cancer types (Table 3). DISCUSSION Using large-scale national data, this study identified the factors associated with the use of combined versus single hospice care and the timing of hospice initiation among Korean adult cancer decedents. In doing so, it also examined the extent to which the integrated provision of the three hospice service types has translated into earlier and more accessible combined hospice care. Among the participants, the rate of combined hospice care use was 18.7%. Interpreted within Andersen’s behavioral model, our findings indicate that enabling factors were the predominant determinants of both combined hospice use and its timing. Characteristics of the healthcare delivery system—regional location, type of the primary medical institution, and hospice designation—exerted larger effects than predisposing factors such as sex or age. This pattern suggests that combined hospice utilization in Korea is shaped less by individual predisposition than by the structural availability of hospice resources, with need factors (comorbidity and cancer type) operating within these structural constraints. From a policy perspective, the dominance of enabling factors implies that improving the equitable distribution of combined hospice infrastructure—rather than targeting individual patient characteristics—is the most direct means of expanding access. In the highest-income class, the probability of using a combined hospice was significantly higher than that in other classes. A previous study [19] stated that the utilization rate of healthcare services among the extremely poor is low because income levels and healthcare use generally show a positive correlation. If such a difference exists between income classes, this deviates from the equity of healthcare use that healthcare services should provide according to medical rather than economic needs [20]. As such, the higher the income, the greater use of combined hospice services were used; the lower the income, the lower the use of healthcare and combined hospice services were used. The situation of using a single-type hospice that focuses on hospitalization should be considered from various perspectives. The residential area of patients with terminal cancer, type and location of the primary medical institution, and whether the residential area and location of the primary medical institution are significant factors influencing the use of a combined hospice. However, previous studies have reported inconsistent results. Hong et al. [21] stated that cancer is not affected by geographical conditions when choosing a medical institution. However, Kim [22] stated that accessibility to healthcare is related to the distance to the medical institution, and available medical resources in the residential area. Based on this study’s results, patients with terminal cancer who live in metropolitan cities or capital areas and mainly use general hospitals located in a capital city or metropolitan cities designated as a hospice organization have the highest possibility for utilizing combination hospice care and initiating it early. Patients with cancer need to be linked to consultative and home-based hospices after cancer treatment or surgery, but when access to a specialized hospice institution is difficult, they have no choice but to use a general ward near their residence or select an inpatient hospice service. These results show that terminally ill cancer patients living in rural areas have difficulty accessing combined hospice care because of a lack of institutions providing combined hospice care in Korea’s rural areas. The finding that patients whose primary medical institution was a general hospital or clinic had a higher OR for using combination-type hospice can be explained by provider-side structural characteristics. In other words, these institutions were more likely to be equipped with the infrastructure to offer combined services, which in turn influenced patient utilization patterns. To support this explanation, our analysis of 2019 data from the National Hospice Center [17] on hospice institutions revealed that among the 51 general hospitals operating hospice services, approximately 45.1% (n=23) were multi-service institutions offering two or more types of care. Notably, the proportion of these hospitals providing a combination of “home-based and inpatient” services (27.5%), which supports patients in their communities, was more than double that of tertiary hospitals (12.5%). Similarly, among the 13 clinics providing hospice care, a majority—53.8% (n=7)—offered combined “home-based and inpatient” services rather than inpatient care alone. Therefore, our findings suggest that the types of hospice services offered by a patient’s primary medical institution directly influenced their likelihood of utilizing combination-type hospice care. In Korea, the order of cancer for men was: stomach, colon, prostate, lung, and liver cancers, whereas for women, it was breast, colon, stomach, lung, and liver cancers. Cancers with low five-year survival rates after onset include pancreatic, gallbladder/bile duct, lung, and liver cancers, and the survival rate is lower in men than in women [23]. The combined hospice utilization rate of pancreatic cancer, which has the lowest survival rate, was second to that of colon cancer, and the combined hospice utilization rate was highest in colon cancer. The reason for the high hospice utilization rate in patients with terminal pancreatic cancer with a low survival rate, or colon cancer with a high prevalence can be interpreted as the result of good hospice linkage, such that, patients with terminal cancer can use palliative care for pain control and symptom relief. The lower utilization of combination-type hospice among patients with lung cancer is likely attributable to their high symptom burden and rapid disease trajectory. This is consistent with the findings of Youk et al. [4], who reported that, relative to single inpatient hospice use, patients with lung cancer had a significantly elevated likelihood of using single consultative hospice (OR=1.134). Such a pattern suggests that end-of-life care for lung cancer patients is often initiated within the acute hospital setting, which inherently limits the opportunity for a planned transition to community-based or combination-type services. In this study, decedents with cancer were analyzed to have started hospice care utilization 34.1 (34.1±37.2) days before death. In the study by Christakis and Iwashyna [24], the median time of hospice enrollment was 30 days (interquartile range: 10~86 days) before death, and in another study by Tang et al. [6], the median time was 20 days (interquartile range: 7~46 days) before death. The previous study’s results are similar to the hospice care initiation timing of single hospice users in this study. According to the multiple regression results in this study, combined hospice users started using hospice care 25.7 days earlier than single hospice users. This is supported by Gidwani et al. [25], who reported that the late referral rate of patients who used both home and inpatient hospice care was significantly lower. Our finding that combination-type users initiated hospice care earlier suggests that using multiple service type can facilitate timely access. This, in turn, may indicate that the national policy objective of expanding hospice accessibility has been partially achieved. Earlier referrals to hospice care may maximize the benefits of hospice care [26]. However, there is no consensus regarding the optimal timing of hospice care initiation among patients with terminal cancer. Some studies [24-26] defined the initiation of hospice care at ≤7 days before death as late hospice initiation. A study [27] reported that enrollment at 58~103 days before death was the most optimal, while another [28] reported that enrollment at 15~30 days was the most optimal. Therefore, it is necessary to conduct research on the optimal initiation of hospice care considering Korea’s cultural context and healthcare systems. Our study found that patients with leukemia had a lower OR for using combination-type hospice and initiated these services significantly later. This finding is strongly supported by LeBlanc et al. [29], who show that patients with hematologic malignancies are more likely to receive aggressive care at the end of life—including dying in the hospital and receiving chemotherapy closer to death—compared to patients with solid tumors. This enduring focus on aggressive, hospital-based treatment inherently limits the window of opportunity for a planned transition to combination-type hospice care. In contrast, the earlier initiation of combination-type hospice among patients with prostate cancer is likely due to its relatively predictable illness trajectory [30]. The gradual progression of advanced prostate cancer allows for more proactive care planning, which facilitates earlier hospice referrals. This extended timeframe for planning is a key facilitator for combination-type hospice, as this model—by its nature—requires the proactive coordination of services between home and inpatient settings. This study has a few limitations. First, because it used secondary data, data on factors affecting healthcare utilization, such as educational level, occupation, and marital status, could not be obtained. Second, the home and consultative hospice care used were pilot project data collected before institutionalization. Therefore, additional research using data obtained after institutionalization is required. SUPPLEMENTARY MATERIALS Supplementary materials can be found via https://doi.org/10.14475/jhpc.2026.29.3.76.